背景:血管激光可能是一种有希望的眶周静脉治疗选择。本文旨在:(1)系统回顾有关血管激光治疗眶周静脉的安全性和有效性的文献,以及(2)通过回顾性病例系列评估安全性和有效性。
方法:系统评价:纳入评估血管激光治疗眶周静脉的安全性和有效性的文章,并使用Downs和Black检查表评估质量。
方法:回顾性回顾了2020年1月至2023年11月的患者记录,以确定所有接受眼眶周围静脉激光治疗的患者。结果评估包括改善百分比,患者总体满意度和不良反应。
结果:系统评价:包括三篇文章,讨论蓝色的治疗,使用1064nmNd:YAG激光的眶周静脉。患者FitzpatrickI-IV型皮肤以很高的患者满意度和治疗静脉的完全清除进行治疗。副作用包括疼痛,红斑,轻度水肿,荨麻疹和水疱形成。纳入研究的质量范围为21分中的7至14分。
方法:纳入34例I-V型皮肤患者。分别使用1064和532nm波长处理蓝色和红色眶周静脉。平均改善百分比为4.8(完全解决),患者的总体满意度排名为3(完全满意)。副作用包括红斑,水肿,还有瘀伤.
结论:使用532和1064nm血管激光治疗红色和蓝色眶周静脉似乎是一种安全的治疗选择。该程序恢复时间短,患者能够在治疗后1天内恢复正常活动。
BACKGROUND: Vascular lasers may represent a promising treatment option for periorbital
veins. This article aims to: (1) systematically review the literature on the safety and effectiveness of vascular laser treatment for periorbital veins and (2) assess safety and effectiveness through a retrospective
case series.
METHODS: Systematic review: Articles that assessed the safety and effectiveness of vascular laser treatment for periorbital
veins were included and quality assessed using the Downs and Black checklist.
METHODS: Patient records were retrospectively reviewed from January 2020 to November 2023 to identify all patients who underwent laser treatment for periorbital
veins. Outcomes assessment included percentage improvement, patient overall satisfaction and adverse effects.
RESULTS: Systematic review: Three articles were included, discussing treatment of blue, periorbital veins using a 1064 nm Nd:YAG laser. Patient Fitzpatrick skin Types I-IV were treated with high patient satisfaction rates and complete clearance of treated veins. Adverse effects included pain, erythema, mild oedema, urticaria and blister formation. Quality of included studies ranged from 7 to 14 out of 21 points.
METHODS: Thirty-four patients with skin Types I-V were included. Blue and red periorbital
veins were treated using 1064 and 532 nm wavelengths respectively. Mean percentage improvement was 4.8 (complete resolution) and patients\' overall satisfaction was ranked 3 (completely satisfied). Adverse effects included erythema, oedema, and bruising.
CONCLUSIONS: Treatment of red and blue periorbital veins using 532 and 1064 nm vascular lasers appears a safe treatment option. The procedure has a short recovery time, with patients able to resume normal activities within 1 day of treatment.